Global Cancer Biomarkers Market Builds on Growing R&D and Reimbursement Support
The global cancer biomarkers market is entering a sustained growth cycle as cancer incidence rises and clinical decision-making becomes increasingly data-driven. Growth is being driven by the shift from broad-spectrum oncology to personalized medicine, the expansion of liquid biopsy and multi-omics testing, and the growing role of biomarkers in companion diagnostics, drug development,...
0 Comments 0 Shares 17 Views 0 Reviews